Welcome to Hemostemix Inc.
Hemostemix is an autologous (patient’s own) stem cell therapeutics company that holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 have been used as a treatment of 500 subjects, studied in including clinical trials, and are demonstrated to be completely safe and effective as a treatment of Angina, Dilated and Ischemic Cardiomyopathy, Peripheral Arterial Disease and Critical Limb Ischemia.
Drawn from your blood, differentiated into ACP-01 and reintroduced into your heart by your physician seven days later,for example, ACP-01 forms new circulation where the body signals it needs regeneration. It’s why we globally trademarked “Your Fountain of Youth!”
Hemostemix Inc. has two wholly owned subsidiaries, Kwalata Trading Limited (IP Hold Co.) and PreCerv Inc. PreCerv holds a global field of use license to ACP-01 & NCP-01 for the treatment of conditions of the central and peripheral nervous system.
Call me (905-580-4170) to discuss joining management and directors as a shareholder. We have greater than $8 Million invested. I think you will be very pleased in the fullness of time.
“In a phrase our trademark, Your Fountain of Youth, explains both the therapeutic benefit of ACP-01 and our business model,”
CEO THOMAS SMEENK
What is critical limb ischemia?
Critical limb ischemia (CLI) is a severe blockage of the arteries and lower extremities which immensely reduces the blood flow. It is an advanced form of peripheral artery disease (PAD) but less common than claudication. It is a condition where the arteries that supply blood to the legs and feet become severely narrowed or blocked, resulting in reduced blood flow and oxygen supply to these areas. This reduced blood flow can lead to severe pain, skin ulcers, tissue damage, and even gangrene, which is the death of tissue.
Symptoms of Critical Limb Ischemia may include leg pain or cramping, especially during exercise or while walking, cold or numb feet or toes, and sores or ulcers that do not heal. The condition is more common in people over the age of 50, smokers, and those with a history of diabetes, high blood pressure, or high cholesterol.
If left untreated, CLI can lead to serious complications such as amputation, stroke, or heart attack. Treatment for CLI typically involves a combination of medications, lifestyle changes, and in severe cases, invasive procedures such as angioplasty or bypass surgery.
In summary, critical limb ischemia is a serious condition that affects the blood circulation in the legs and feet, and can lead to severe pain and tissue damage if left untreated. It is important to seek medical attention if you experience any symptoms of the condition to prevent further complications.
What is peripheral artery disease?
Peripheral Artery Disease (PAD) is a circulatory condition that occurs when the arteries in the legs, stomach, arms, and head become narrowed or blocked with plaque. The narrowing and blockage occur due to the buildup of cholesterol and other fatty deposits inside the walls of the blood vessels.
PAD is caused by atherosclerosis, which is a condition where the arteries become stiff and narrow due to the accumulation of fatty deposits. This condition reduces blood flow to the affected limbs, causing symptoms such as leg pain, numbness, weakness, and cramping. In severe cases, PAD can lead to gangrene, amputation, and other serious complications.
Risk factors for PAD include smoking, diabetes, hypertension, high cholesterol, and a family history of the disease. The condition is more common in people over age 50 and in those who have a history of cardiovascular disease.
Diagnosis of PAD involves a physical examination and various tests such as ankle-brachial index (ABI), Doppler ultrasound, blood tests, and angiography. Treatment options for PAD include lifestyle changes such as quitting smoking, adopting a healthy diet, and exercising regularly. Medications like blood thinners, cholesterol-lowering drugs, and blood pressure medications may also be prescribed. In severe cases, surgery or angioplasty may be required to restore blood flow to the affected limb.
In conclusion, Peripheral Artery Disease is a serious condition that affects the arteries in the legs, arms, stomach, and head. It is caused by the buildup of plaque in the arteries and can lead to various complications if left untreated. Understanding the risk factors, symptoms, and treatment options for PAD is crucial in managing the condition and preventing serious complications.
What is ischemic cardiomyopathy?
Ischemic cardiomyopathy is a type of heart disease that occurs when the heart muscle becomes damaged due to insufficient blood flow to the heart. This can happen when the arteries that supply blood to the heart become narrowed or blocked, usually due to the buildup of fatty deposits called plaque.
When the heart muscle is deprived of oxygen and nutrients due to reduced blood flow, it can become weakened and damaged, which can lead to symptoms such as chest pain, shortness of breath, fatigue, and even heart failure.
Ischemic cardiomyopathy is typically caused by coronary artery disease, which is the most common form of heart disease. Risk factors for developing this condition include high blood pressure, high cholesterol, smoking, obesity, and a family history of heart disease.
Treatment for ischemic cardiomyopathy may include lifestyle changes such as exercise and a healthy diet, medications to control blood pressure and cholesterol, and procedures such as angioplasty or bypass surgery to restore blood flow to the heart.
It’s important for individuals with risk factors for heart disease to monitor their health and seek medical attention if they experience symptoms of ischemic cardiomyopathy or other forms of heart disease. By managing risk factors and seeking prompt treatment, individuals can reduce their risk of developing this condition and improve their overall heart health.
Applying Stem Cell Therapy For CLI To Save At Risk Limbs
Hemostemix has developed an enhanced cell therapy that restores blood flow in patients with Critical Limb Ischemia (CLI), saving 93.5% of limbs in a Phase 2 trial.
With Hemostemix ACP-01 treatment options for CLI or PAD patients to improve their quality of life. ACP-01 is a safe and effective stem cell therapy for the treatment of CLI, a loss of circulation (atherosclerosis) in the limbs that leads to severe pain, ulcerating wounds, gangrene and amputation.
ACP-01 as a treatment of heart disease (ischemic cardiomyopathy), demonstrated statistically significant improvements in 245 patients who participated in one of three phase 1 studies (171 subjects), or who were consecutively treated compassionately for ischemic cardiomyopathy (74 subjects) and studied retrospectively.